Is the expression of matrix metalloproteinases (MMP-2, -9) and tissue inhibitors of metalloproteinases (TIMP-1, -2, and -3) associated with angiogenesis and clinicopathological features for breast cancer?. JHSCI [Internet]. 2017 Dec. 20 [cited 2024 May 7];7(3):158-6. Available from: https://www.jhsci.ba/ojs/index.php/jhsci/article/view/620